Budesonide once versus twice-daily administration: Meta-analysis

Respirology

Volumn 9, Issue 4, 2004, Pages 528-534

  Masoli, Matthew ^a   Weatherall, Mark ^b   Holt, Shaun ^c   Beasley, Richard ^a,d  

^a MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c P3 Research   (New Zealand)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Asthma; Budesonide; Compliance; Meta analysis; Once daily

Indexed keywords

BUDESONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG WITHDRAWAL; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 13144251136     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2004.00635.x     Document Type: Article

References (30)

1. Cochrane GM. Assessment of compliance. In: O'Byrne PM, Thomson NC (eds). Manual of Asthma Management, 2nd edn. W.B. Saunders, London, 2001; 323-8.
2. Chmelik F, Doughty A. Objective measurements of compliance in asthma treatment. Ann. Allergy 1994; 73: 527-32.
3. Coutts JA, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch. Dis. Child 1992; 67: 332-3.
4. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin. Ther. 2001; 23: 1296-310.
5. Campbell LM. Once-daily inhaled corticosteroids in mild to moderate asthma, improving acceptance of treatment. Drugs 1999; 58 (Suppl. 4): 25-33.
6. Whitehead A. Meta-Analysis of Controlled Clinical Trials. J. Wiley and Sons, Chichester, 2002.
7. Mintz S, Alexander M, Li JH, Mayer PV. Once-daily administration of budesonide Turbuhaler was as effective as twice-daily treatment in patients with mild to moderate persistent asthma. J. Asthma 2002; 39: 203-10.
8. Venables T, Addlestone M, Smithers A et al. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbuhaler and twice daily fluticasone via disc-haler at an equal daily dose of 400 μg in adult asthmatics. Br. J. Clin. Res. 1996; 7: 15-32.
9. Gunn S, Choudhury M, Burnett R, Black H, Turbitt M. Inhaled steroid treatment reduction in stable asthmatics: a comparison of beclomethasone/ budesonide metered dose inhaler with half dose treatment using budesonide Turbuhaler given once or twice daily. Br. J. Clin. Res. 1997; 8: 67-80.
10. Herjavecz I, Blomqvist P, Serrano A. Efficacy of once-and twice-daily administration of budesonide via Turbuhaler as initial therapy in patients with mild persistent asthma. Respir. Med. 1999; 93: 230-5.
11. Chisholm SL, Dekker FW, Knuistingh Neven A, Petri H. Once-daily budesonide in mild asthma. Respir. Med. 1998; 92: 421-5.
12. Campbell L, Gunn S, Sweeny D et al. Once daily budesonide: effective control of moderately severe asthma with 800 μg once daily inhaled via Turbuhaler when compared to 400 μg twice daily. Eur. J. Clin. Res. 1995; 7: 1-14.
13. Jones AH, Langdon CG, Lee PS et al. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma. Respir. Med. 1994; 88: 293-9.
14. Campbell LM, Bodalia B, Gogbashian CA, Gunn SD, Humphreys PJ, Powell JP. Once daily budesonide: 400 μg once daily is as effective as 200 μg twice daily in controlling childhood asthma. PETITE Research Group. Int. J. Clin. Pract. 1998; 52: 213-19.
15. Moller C, Stromberg L, Oldaeus G, Arwestrom E, Kjellman M. Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler in children with stable asthma. Pediatr. Pulmonol. 1999; 28: 337-43.
16. Jönasson G, Carlsen K-H, Blomqvist P. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. Eur. Respir. J. 1998; 12: 1099-104.
17. Heuck C, Wolthers OD, Kollerup G, Hansen M, Teisner B. Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration. J. Pediatr. 1998; 133: 608-12.
18. Vervloet D, Fontaine T, Bernabeu L, Galliot P, Ostinelli J. Once daily budesonide 800 μg is as effective and safe as 400 μg twice daily in patients with moderate to severe asthma. Am. J. Respir. Crit. Care Med. 2002; 165: A769.
19. Weiner P, Weiner M, Azgad Y. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma. Thorax 1995; 50: 1270-3.
20. Jatakanon A, Kharitonov S, Lim S, Barnes PJ. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999; 54: 108-14.
21. Lipworth BJ, Aziz I, Wilson AM. Effects of formoterol (FM) and budesonide (BUD), alone or combined, on adenosine monophosphate (AMP) challenge and exhaled nitric oxide (NO). J. Allergy Clin. Immunol. 1999; 103: S60.
22. Edsbacker S, Brattsand R. Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data. Ann. Allergy Asthma Immunol 2002; 88: 609-16.
23. Shapiro GG, Mendelson LM, Pearlman DS. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. Ann. Allergy Asthma Immunol. 2001; 86: 633-40.
24. McFadden ER, Casale TB, Edwards TB et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. J. Allergy Clin. Immunol. 1999; 104: 46-52.
25. Masoli M, Holt S, Weatherall M, Beasley R. Dose-response relationship of inhaled budesonide in adult asthma: a meta-analysis. Eur. Respir. J. 2004; 23: 552-8.
26. Szefler SJ, Martin RJ, King TS et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J. Allergy Clin. Immunol. 2002; 109: 410-8.
27. Thorsson L, Kallen A. A randomized controlled assessment of the systemic activity of budesonide when given once or twice daily via Turbuhaler. Eur. J. Clin. Pharmacol. 2000; 56: 207-10.
28. Leflein J. Once daily use of inhaled corticosteroids: a new regimen in the treatment of persistent asthma. Allergol. Int. 2000; 49: 7-17.
29. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch. Intern. Med. 1990; 150: 1881-4.
30. Hyland ME. Rationale for once-daily therapy in asthma: compliance issues. Drugs 1999; 58 (Suppl. 4): 1-6.